ArticleCancer immunology research2019

A Synthetic DNA, Multi-Neoantigen Vaccine Drives Predominately MHC Class I CD8

Elizabeth K Duperret et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.